Skip to content

Advertisement

Radiation Oncology

What do you think about BMC? Take part in

Open Access

Erratum: Changes in circulating microRNAs after radiochemotherapy in head and neck cancer patients

  • Isolde Summerer1,
  • Maximilian Niyazi2,
  • Kristian Unger1, 4,
  • Adriana Pitea1,
  • Verena Zangen1, 4,
  • Julia Hess1, 4,
  • Michael J Atkinson3,
  • Claus Belka2, 4,
  • Simone Moertl3 and
  • Horst Zitzelsberger1, 4Email author
Radiation Oncology201510:102

https://doi.org/10.1186/s13014-015-0394-8

Received: 25 March 2015

Accepted: 25 March 2015

Published: 24 April 2015

The original article was published in Radiation Oncology 2013 8:296

Erratum

After the publication of this work [1], a few points were brought to our attention:

The clinical data of patient 2 are incorrect. A revised version of Table 1 [1] showing the corrected patient characteristics is presented here. Consequently, the description of the patient cohort in the Materials and Methods section is incorrect. The correct description is: “Plasma miRNA analysis was performed on 18 HNSCC patients treated with local X-ray-irradiation using a linear accelerator […].
Table 1

Patient characteristics

Characteristic

Number of patients

Gender

 

  Male

14

  Female

4

Median age, years

57.5

Age range, years

45.1–80.6

Tumor site

 

  Larynx

5

  Oropharynx

3

  Mouth floor

2

  Tongue

2

  Hypopharynx

1

  Maxilla

1

  Nasopharynx

1

  Sinuses

1

  Soft palate

2

T-Stage

 

  I

4

  II

3

  III

5

  IV

6

N-Stage

 

  N0

3

  N1

4

  N2

11

M-Stage

 

  M0

17

  M1

1

Concomitant therapy (in addition to radiotherapy)

 

  5-FU + MMC

13 (patient 2, 3, 5–7, 9–13, 15–17)

  MMC

3 (patient 1, 14, 18)

  Cisplatin

1 (patient 8)

  Cetuximab

1 (patient 4)

Acute toxicity

 

  Severe

12

  Moderate

5

  n.a.

1

5-FU = 5-fluorouracil; MMC = mitomycin C; n.a. = not available.

17 out of 18 patients received concurrent chemotherapy (13 patients received 5-fluorouracil (5-FU) plus mitomycin C (MMC) [21], 3 patients MMC and 1 patient cisplatin weekly)”.

There is a typing error in the Results section [1] concerning the p value of the up-regulation of miR-425-5p. The correct sentence is:

“The qRTPCR assays confirmed an up-regulation of miR-425-5p with a p value close to the significance level (p = 0.052) […]”.

The corrections do not affect any results or conclusions of the published work.

Notes

Authors’ Affiliations

(1)
Research Unit Radiation Cytogenetics, Helmholtz Center Munich
(2)
Department of Radiation Oncology, University of Munich
(3)
Institute of Radiation Biology, Helmholtz Center Munich
(4)
Clinical Cooperation Group ‘Personalized Radiotherapy of Head and Neck Cancer’, Helmholtz Center Munich

Reference

  1. Summerer I, Niyazi M, Unger K, Pitea A, Zangen V, Hess J, et al. Changes in circulating microRNAs after radiochemotherapy in head and neck cancer patients. Radiat Oncol. 2013;8:296.View ArticlePubMed CentralPubMedGoogle Scholar

Copyright

© Summerer et al.; licensee BioMed Central. 2015

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Advertisement